MXCT
Maxcyte
$1.02
−$0.06 (−5.56%)Jul 27, 2026
Key metrics
The numbers that frame MXCT today
- Market cap
- $109.26M
- P/E (TTM)
- -2.8
- EV / FCF
- -3.8
- Gross margin
- 80.5%
- EV / Sales
- 3.5
- ROIC
- -20.1%
- Div yield
- 0%
- Debt / equity
- 0.1
- 52wk Low
- $0.64
- 52wk High
- $2.31
Growth
Revenue and earnings trend for MXCT
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about MXCT
Is Maxcyte a good buy?
Hold. Maxcyte has weak quality and weak momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case. We think Maxcyte is selling at a very high price.
What is the market capitalization of MXCT?
Maxcyte's market capitalization is $109.26M.
What is the P/E ratio for MXCT stock?
Maxcyte's current P/E ratio is -2.8.
What is the 52-week high for MXCT stock?
The 52-week high for Maxcyte is $2.31. The current close of $1.02 is 55.7% below that high.
What is the 52-week low for MXCT stock?
The 52-week low for Maxcyte is $0.64. The current close of $1.02 is 58.6% above that low.
Does MXCT stock pay dividends?
Maxcyte does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for MXCT?
Maxcyte's Debt / Equity ratio is 0.1.